Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Compounds-that-bind-to-digitalis-receptor

 Rapid assaying method for guanase
What we claimed is: 1. In the method of assaying guanase in the sample of the body fluid by adding ...


 Method and mixture for producing an artificial skiing track
What is claimed is: 1. In a method for producing an artificial track for skiing in all seasons, the ...


 Method for simultaneously monitoring turnover rate in multiple proteins
The invention provides an assay method for cellular and extracellular protein biodynamics ...


 Immunoassays using support-containing separate antigens and antibodies derived from an immune complex
What is claimed is: 1. A process for the detection of an antigen in a specimen which process ...


 Bile acid sulfate sulfatase, process for its preparation and method for assaying bile acid
We claim: 1. A method for the preparation of bile acid sulfate sulfatase comprising the steps of ...


 Processes for producing glucan using Elsinoe
The object of the present invention is to develop a new glucan which is utilizable not only in the ...


 Sustained release polymers
I claim: 1. A water soluble copolymer consisting essentially of from 20 to 60 parts of at least one ...


 Vaccine compositions
OF THE INVENTION Target cells are inactivated by treatment with psoralens and irradiation with LWUV...


 Cyanobenzyl cyclopropane carboxylate pesticides
We claim: 1. A method of combating insect or acarid pests at a locus which comprises applying to ...


 Aqueous flowable concentrates of particulate water-insoluble pesticides
What is claimed is: 1. A flowable, viscous, aqueous pesticidal concentrate which is compatible with ...


 Compounds that bind to digitalis receptor

Details
Inventors: LaBella, Frank S.; Templeton, John F.;
Assignee: University of Manitoba (Winnipeg, CA)
Primary Examiner: Brown; Johnnie R.
Assistant Examiner: Carson; Nancy S.
Attorney, Agent or Firm: Sim & McBurney

Novel steroid compounds which are glycoside derivatives of 14.beta.-hydroxypregnane and 17.alpha.-acetoxy-6.alpha.-methylpregnane are described. The compounds have increased receptor potency when compared to their aglycone and beneficial renal effects.

DETAILED DESCRIPTION What we claim is: 1.
A C3-glycoside derivative of a 14.
beta.
-hydroxypregnane and having the formula: ##STR9## wherein GLY is a glycoside radical selected from the group consisting of glucoside, rhamnoside and tridigitoxoside.
2.
A C3-glycoside derivative of a 14.
beta.
-hydroxypregnane and having the formula: ##STR10## where GLY is a glycoside radical selected from the group consisting of glucoside, rhamnoside and tridigitoxoside and R is an amino group.




Description:
FIELD OF INVENTION The present invention relates to certain novel steroid compounds which exhibit novel effects which suggest utility as heart stimulants.
BACKGROUND TO THE INVENTION The digitalis-derived steroid glycosides have been among the most widely-prescribed drugs.
Digoxin today is the most favored digitaloid in the clinic and is extensively used to treat certain cardiac dysfunctions.
The cardiac glycosides bind with high affinity and high specificity to a Na.
sup.
+ - and K.
sup.
+ -transporting ATPase.
It is generally accepted that inhibition of this cellular enzyme by the cardiac glycosides initiates a series of events in the cardiac muscle that lead to increased contractility.
Weiland et al in J.
Enz.
Inhib.
2:31 to 36, 1987 have described the effect of forming glycosides of chloramidone acetate (CMA).
It had previously been observed that CMA had a high affinity for Na/K-ATPase but causes cardiodepression or decreased contractility, which overrides any positive effects on contractility that otherwise result from inhibition of the Na.
sup.
+ /K.
sup.
+ pump.
Certain glycoside derivatives of CMA, namely the arabinofuranoside and the rhamnoside derivatives, are described by Weiland et al and were tested for Na.
sup.
+ /K.
sup.
+ -ATPase inhibition and in vivo inotropic activity, in comparison with the hydroxy derivatives of CMA and digoxin.
A decreased potency for the glycosides was observed when compared to the hydroxy derivative of CMA and digoxin (itself a glycoside) but the glycosides increased contractility, in comparison with the depressive action of CMA



Related patents
  Reticulated cellulose and methods and microorganisms for the production thereof
The present invention includes a reticulated bacterial cellulose product having novel properties. This reticulated bacterial cellulose product is characterized by a ...
  Glycopetide antibiotic PA-45052-B
OF THE INVENTION The present inventors found that the strain belonging to the genus Nocardia produces compounds which are represented by the following formula: ##STR2## ...
  Production of pure sugars and lignosulfonates from sulfite spent liquor
According to the present invention, sulfite spent liquor is subjected to a two-step chromatographic separation to form substantially purified fractions of sugars and ...
  Chromatographic separator sorbent bed preparation
This invention provides a sorbent bed packing procedure which minimizes sorbent bed compartment void space and provides a sorbent bed of increased density in a ...
  Simulated moving bed chromatographic separation
What is claimed is: 1. In a method for the separation of an extract component from a raffinate component contained in a fluid feed stream in a simulated moving bed ...
  Method for fractionating sulphite cooking liquor
We claim: 1. A method for the fractionation of sulphite cooking liquor by a sequential chromatographic simulated moving bed system in which the liquid flow is effected ...
  Method for cloning and producing the Msel restriction endonuclease
OF THE INVENTION In one embodiment, the present invention relates to a method of producing a target restriction endonuclease by first providing a vector expressing a ...
  Xanthine oxidase
I claim: 1. A milk xanthine oxidase active enzyme concentrate having an average protein to flavin ratio as measured by E.sub.280nm for protein and E.sub.450nm for flavin ...
  Silver halide photographic light-sensitive materials
Accordingly, an object of the present invention is to provide highly sensitive silver halide photographic light-sensitive materials which form images having high ...
  Ligand analog-irreversible enzyme inhibitor conjugates and methods for use
OF THE INVENTION The present invention relates to methods and reagents for determining ligands in biological fluids such as serum, plasma, spinal fluid, amnionic fluid ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved